| 0 (0%) | 06-20 13:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 11.09  |
1-year : | 12.96 |
| Resists | First : | 9.5 |
Second : | 11.09 |
| Pivot price | 8.38 |
|||
| Supports | First : | 7.99 |
Second : | 7.05 |
| MAs | MA(5) : | 8.6 |
MA(20) : | 8.15 |
| MA(100) : | 9.34  |
MA(250) : | 16.04 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 82.1 |
D(3) : | 70.8 |
| RSI | RSI(14): 60.5 |
|||
| 52-week | High : | 33.63 | Low : | 7.05 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ EVH ] has closed Bollinger Bands are 10.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.85 - 8.89 | 8.89 - 8.93 |
| Low: | 8.25 - 8.3 | 8.3 - 8.34 |
| Close: | 8.57 - 8.65 | 8.65 - 8.72 |
Fri, 20 Jun 2025
Evolent Health (EVH) Rating Reaffirmed by JMP Securities | EVH Stock News - GuruFocus
Fri, 20 Jun 2025
Evolent Health (EVH) Optimistic About FY25 EBITDA Amid Favorable Trends | EVH Stock News - GuruFocus
Fri, 20 Jun 2025
Evolent reiterates Q2 and full year guidance for Adjusted EBITDA - PR Newswire
Tue, 10 Jun 2025
EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus - Yahoo Finance
Thu, 29 May 2025
Slide Into Summer in EVH Style! - Van Halen News Desk
Wed, 28 May 2025
Review: EVH SA-126 Standard Semi-Hollow Electric Guitar - Mixdown Magazine
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 117 (M) |
| Shares Float | 104 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 109.5 (%) |
| Shares Short | 16,720 (K) |
| Shares Short P.Month | 16,090 (K) |
| EPS | -1.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.06 |
| Profit Margin | -4.6 % |
| Operating Margin | 0.3 % |
| Return on Assets (ttm) | -0.1 % |
| Return on Equity (ttm) | -9.3 % |
| Qtrly Rev. Growth | -24.4 % |
| Gross Profit (p.s.) | 3.11 |
| Sales Per Share | 20.44 |
| EBITDA (p.s.) | 0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 18 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -7.72 |
| PEG Ratio | 0 |
| Price to Book value | 1.16 |
| Price to Sales | 0.46 |
| Price to Cash Flow | 59.97 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|